A comparison of Huntington disease and Huntington disease-like 2 neuropathology

被引:65
作者
Rudnicki, Dobrila D. [1 ]
Pletnikova, Olga [2 ]
Vonsattel, Jean-Paul G. [3 ]
Ross, Christopher A. [4 ,5 ]
Margolis, Russell L. [4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Psychiat, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Pathol, Baltimore, MD USA
[3] Columbia Univ, Med Ctr, Columbia Presbyterian Med Ctr, New York, NY USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurol,Program Cellular & Mol Med, Div Neurobiol,Dept Psychiat, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neursci,Program Cellular & Mol Med, Div Neurobiol,Dept Psychiat, Baltimore, MD 21205 USA
关键词
myotonic dystrophy; neurodegeneration; trinucleotide;
D O I
10.1097/NEN.0b013e31816b4aee
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington disease-like 2 (HDL2) is an autosomal dominant disorder characterized by adult-onset, progressive motor abnormalities, psychiatric disturbances, and dementia ending in premature death. Clinically, it most closely resembles Huntington disease (HD), although a subset of affected individuals have parkinsonian features. Here, we systematically compare 5 HDL2 and 5 HD brains with the hypothesis that, reflecting the clinical presentation, the neuropathology of the 2 diseases would be similar. Gross and microscopic examination revealed prominent striatal neuron loss and astrocytic gliosis in a dorsal to ventral gradient in each disorder and cortical atrophy. Nuclear protein aggregates were as common in HDL2 as in HID, and the ultrastructural features of HDL2 and HD aggregates were similar. Electron microscopy also revealed degenerating neurons, some with evidence of autophagy, in both HDL2 and HD. Small ribonuclear foci, previously associated with potentially neurotoxic RNA transcripts in HDL2, rarely colocalized with protein aggregates in HDL2 brain, although the protein aggregates were stained by anti-TATA-box binding protein antibodies. Overall, the neuropathologic features of HDL2 and HD are very similar but not identical, suggesting that the pathogenetic mechanisms of the 2 diseases may partially overlap.
引用
收藏
页码:366 / 374
页数:9
相关论文
共 50 条
  • [21] Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice
    Petkau, Terri L.
    Hill, Austin
    Connolly, Colum
    Lu, Ge
    Wagner, Pam
    Kosior, Natalia
    Blanco, Jake
    Leavitt, Blair R.
    HUMAN MOLECULAR GENETICS, 2019, 28 (10) : 1661 - 1670
  • [22] Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in mice
    Creus-Muncunill, Jordi
    Guisado-Corcoll, Anna
    Venturi, Veronica
    Pantano, Lorena
    Escaramis, Georgia
    Garcia de Herreros, Marta
    Solaguren-Beascoa, Maria
    Gamez-Valero, Ana
    Navarrete, Cristina
    Masana, Merce
    Llorens, Franc
    Diaz-Lucena, Daniela
    Perez-Navarro, Esther
    Marti, Eulalia
    ACTA NEUROPATHOLOGICA, 2021, 141 (04) : 565 - 584
  • [23] An Antisense CAG Repeat Transcript at JPH3 Locus Mediates Expanded Polyglutamine Protein Toxicity in Huntington's Disease-like 2 Mice
    Wilburn, Brian
    Rudnicki, Dobrila D.
    Zhao, Jing
    Weitz, Tara Murphy
    Cheng, Yin
    Gu, Xiaofeng
    Greiner, Erin
    Park, Chang Sin
    Wang, Nan
    Sopher, Bryce L.
    La Spada, Albert R.
    Osmand, Alex
    Margolis, Russell L.
    Sun, Yi E.
    Yang, X. William
    NEURON, 2011, 70 (03) : 427 - 440
  • [24] Visualization of prion-like transfer in Huntington's disease models
    Jansen, Anne H. P.
    Batenburg, Kevin L.
    Pecho-Vrieseling, Eline
    Reits, Eric A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (03): : 793 - 800
  • [25] Huntingtin processing in pathogenesis of Huntington disease
    Zheng-hong QIN
    Laboratory of Cellular Neurobiology
    ActaPharmacologicaSinica, 2004, (10) : 3 - 9
  • [26] Calpain activation in Huntington's disease
    Gafni, J
    Ellerby, LM
    JOURNAL OF NEUROSCIENCE, 2002, 22 (12) : 4842 - 4849
  • [27] Molecular aspects of Huntington's disease
    Walling, HW
    Baldassare, JJ
    Westfall, TC
    JOURNAL OF NEUROSCIENCE RESEARCH, 1998, 54 (03) : 301 - 308
  • [28] Iron dysregulation in Huntington's disease
    Muller, Michelle
    Leavitt, Blair R.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 (03) : 328 - 350
  • [29] Huntington’s Disease—Update on Treatments
    Kara J. Wyant
    Andrew J. Ridder
    Praveen Dayalu
    Current Neurology and Neuroscience Reports, 2017, 17
  • [30] Huntingtin processing in pathogenesis of Huntington disease
    Qin, ZH
    Gu, ZL
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (10) : 1243 - 1249